Hongjian Zhu PhD

Dr. Hongjian Zhu received his Ph.D. in Statistics from the University of Virginia in 2010 and subsequently completed postdoctoral training at Yale University in 2012. Then he joined UTHealth and was promoted to tenured Associate Professor. Currently, he is a Director in the Statistical Innovation Group at AbbVie Inc. In this role, he offers strategic, innovative thinking and develops novel statistical methodology for various Therapeutic Areas, including Immunology, Oncology, and Eyecare.

His primary research focuses on adaptive clinical trial designs. He has published papers in top-tier journals such as The Journal of the American Statistical Association (JASA), The Annals of Statistics, Biometrics, The Journal of the American Medical Association (JAMA), and The Journals of the American College of Cardiology (JACC). He received funding from the National Science Foundation as the Principal Investigator. He is an Elected Member of the International Statistical Institute (ISI) and president-elect of the Houston Area Chapter of the ASA (HACASA).